Binding mode of cyclic chemerin-9 peptide and chemerinS157 protein at CMKLR.

G protein-coupled receptor binding mode double-mutant cycle analysis peptide

Journal

Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360

Informations de publication

Date de publication:
18 Oct 2024
Historique:
revised: 18 10 2024
received: 20 08 2024
accepted: 18 10 2024
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: aheadofprint

Résumé

The chemokine-like receptor 1 (CMKLR1) is activated by the adipokine and chemoattractant protein chemerin. Cryo-EM structures of chemerin-9-CMKLR1-Gi have been published, where chemerin-9 is the nonapeptide of the C terminus of chemerinS157. Chemerin-9 is as active as the full-length protein in Ca2+-release but shows differences in equilibrium read-outs. An equally potent cyclic chemerin-9 variant (cC9) was reported previously. Now, we have built a computational model of CMKLR1 to investigate the binding mode of cC9 and chemerinS157 in comparison to chemerin-9. Differences were investigated using CMKLR1 variants. Double-mutant cycle analysis identified CMKLR1-F2.53 as the relevant position for Phe8-binding of cC9. Energy contribution revealed slight differences in Phe8-binding to CMKLR1-F2.53 and space for larger residues. This was confirmed as the chemerin-9 variant with 1-naphthyl-L-alanine at position 8 showed a 4-fold increased potency of 2 nM  (pEC50=8.6±0.15). While chemerin-9 and cC9 share their interactions at the CMKLR1, chemerinS157 tolerates most mutations of CMKLR1 in the deep binding site. The computational model of chemerinS157 suggests a β-sheet interaction between the N-terminal CMKLR1-segment I25VVL28 and the β-sheet D108KVLGRLVH116 of ChemS157, which was confirmed experimentally. Our data expand the knowledge by identifying the binding mode of chemerinS157 and cC9 at CMKLR1 facilitating future structure-based drug design.

Identifiants

pubmed: 39424605
doi: 10.1002/cbic.202400695
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202400695

Informations de copyright

© 2024 Wiley‐VCH GmbH.

Auteurs

Tina Schermeng (T)

Leipzig University, Institute of Biochemistry, GERMANY.

Fabian Liessmann (F)

Leipzig University, Institute for Drug Discovery, GERMANY.

Carla Katharina Ambrosius (CK)

Leipzig University, Institute of Biochemistry, GERMANY.

Jens Meiler (J)

Leipzig University, Institute for Drug Discovery, GERMANY.

Annette G Beck-Sickinger (AG)

Universitat Leipzig, Faculty of Bioscience, Pharmacy and Psychology, Bruederstr. 34, Institute of Biochemistry, 04103, Leipzig, GERMANY.

Classifications MeSH